Skip navigation links
Continuing Medical EducationClick for HomeClick for OutlineClick for Faculty BiographyClick for Help
Columbia University College of Physicians and Surgeons | Dementia: Update for the Practitioner
 
 Introduction
 
 Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Karen L. Bell, M.D.
 
 Treatment Strategies for Dementia and Mild Cognitive Impairment
Mary Sano, Ph.D.
 
 Treatment of Depression, Agitation, and Psychosis in Dementia
Davangere P. Devanand, M.D.
 
  Recognition of Vascular Dementia, Dementia with Lewy Bodies, and Frontotemporal Dementia
Lawrence S. Honig, M.D., Ph.D.
 
  Neuropsychology of Mild Cognitive Impairment, Alzheimer's Disease, Dementia with Lewy Bodies, and Frontotemporal Dementia Penne Sims, Ph.D.
 
  Neuroimaging in Dementia
Scott A. Small, M.D.
 
  Genetics of Neurodegenerative Disease: Alzheimer's Disease, Frontotemporal Dementia
Jennifer Williamson-Catania, M.S.
 
  Family Patterns in Alzheimer's Disease
 
 
  Genetics of Early-Onset AD
 
 
  Genetics of Late-Onset AD
 
 
  Genetic Testing for AD
 
 
  Genetic Testing for FTD
 
 
  Why Offer Testing?
 
 
  Legal and Ethical Issues for Patients with Dementia
Daniel G. Fish, Esq.
 
 
Posttest
 
 
 
 
 
Accreditation
 
 
Reference List
 
 
Acknowledgements

 Begin page content 
Genetics of Neurodegenerative Disease: Alzheimer's Disease, Frontotemporal Dementia
Jennifer Williamson-Catania, M.S.

Genetic Testing for FTD
 
As Dr. Honig discussed in his talk, frontotemporal dementia is an umbrella diagnosis for a very complicated list of diseases. There is a great degree of variability that can occur in families, making it difficult to detect a history. Someone whom you suspect has FTD can have a family history of ALS, psychiatric disease, depression, or alcoholism.
 
Studies estimate that about 40 percent of FTD is familial, and of that about 10 percent is linked to mutations in the MAPT gene, microtubule-associated protein TAU. The TAU gene is located on chromosome 17. The children of an individual with a mutation in this gene have a 50-percent risk of inheriting that same disease-causing mutation. The penetrance is 100 percent with variable presentation.
 
Most of the available genetic testing for frontotemporal dementia is research testing; the only clinical testing is available through the University of California at San Francisco (UCSF). UCSF is looking for three common mutations: P301L, A279L, and a splice isoform mutation at position 14 of IVS10. If a family does not have one of those mutations, they will enter into a research study and undergo complete screening for mutations in TAU.
 
     
Genetic Testing Used in FTD

% of families Genetic Mechanism Test Type Test Availability
~10% MAPT gene mutations DNA sequence analysis Research
Unknown 3 common mutations: P301L, A279l, splice isoform mutation at position 14 of IVS10 Allele-specific oligonucleotides Clinical
 
Most of the available genetic testing for frontotemporal dementia is research testing.

Courtesy of Jennifer Williamson-Catania, M.S.
 
 
One family that participated in an early research study that helped find the gene for TAU later came to me with questions. A woman said, "My husband and his brothers participated in a research study, and we know that there is a history of frontotemporal dementia, because two of the three brothers had autopsy-confirmed frontotemporal dementia with onset in their forties. I want to know what this means for our children." They wanted to have genetic counseling for the three wives so that they could then talk to their children and see if their children wanted to get more information and perhaps genetic testing, if it was available.
 
   
Frontotemporal Dementia

Frontotemporal dementia
 
Profile of a family with a history of frontotemporal dementia.

Courtesy of Jennifer Williamson-Catania, M.S.
 
 
This family set me on a course of contacting the people that conducted the research study, and we decided that if the family wanted to know if they had a mutation, we would have to get tissue from the autopsies and confirm that the three known mutations were present. I talked with the family about what it would mean to find a mutation, and the family asked me to present my findings to their children. The family decided not to go any further. The three affected individuals all carry one of the common TAU mutations, but the family does not know it.
 
 
PREVIOUS | NEXT